Can a little extra care make a big difference for cancer trial patients?
NCT ID NCT03667378
First seen Nov 01, 2025 · Last updated May 25, 2026 · Updated 28 times
Summary
This study looks at whether adding personalized supportive care (like help with symptoms and coping) to standard treatment helps people with advanced solid tumors who are starting a Phase I cancer drug trial. About 83 participants will be randomly assigned to get either the extra supportive care or usual care alone. Researchers will compare how well patients discuss their symptoms, future concerns, and coping strategies.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC SOLID TUMOR CANCERS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Memorial Sloan Kettering Cancer Center
New York, New York, 10065, United States
Conditions
Explore the condition pages connected to this study.